About Molprofiles.co.uk
Molprofiles.co.uk is a Healthcare company based in United Kingdom founded in 1997, and was acquired by Juniper Pharma in September 2013. Phase I-IIa clinical development services are provided by this CRO. Molprofiles.co.uk offers products and services including OptiForm Solution Suite, Catalent Spray Drying Technology, and Softgel Technology. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Early Stage. Its legal entity is Catalent, Inc. Its competitors include Open Orphan, AWAKN and Clerkenwell Health; 1 of its 3 listed competitors has raised funding.
Company details
Molprofiles.co.uk, established in 1997, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, and early stage. CRO offering Phase I - IIa clinical development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website molprofiles.co.uk
- Social LinkedIn X Facebook YouTube
- Acquired by Juniper Pharma (Sep 2013)
- Legal Name Catalent, Inc
- Investors
- Acquired byJuniper Pharma
(Sep 2013)
Products & Services of Molprofiles.co.uk
Molprofiles.co.uk offers a comprehensive portfolio of products and services, including OptiForm Solution Suite, Catalent Spray Drying Technology, and Softgel Technology.
Platform for early-phase drug development and bioavailability enhancement
Technology to improve drug solubility and delivery
Method for producing softgel capsules for pharmaceuticals
Apps and channels of Molprofiles.co.uk
its YouTube channel Catalent Pharma Solutions has 7.59K subscribers and 30 videos.
Videos from Molprofiles.co.uk
The most watched videos on Molprofiles.co.uk's YouTube channel, Catalent Pharma Solutions (7.59K subscribers). Click a video to play it here.
More on Catalent Pharma Solutions.
Investors in Molprofiles.co.uk
Molprofiles.co.uk has secured backing from 1 investor. Prominent investors backing the company include Juniper Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty company developing therapeutics for women's health and a CDMO specializing in formulation development, analytical services and clinical manufacturing. | 1986 | juniperpharma.com | Boston, United States |
Investor details for Molprofiles.co.uk
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molprofiles.co.uk
2 dated milestones of Molprofiles.co.uk across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Molprofiles.co.uk is founded.
- Exit Acquired by Juniper Pharma.
Competitors of Molprofiles.co.uk
Molprofiles.co.uk has 3 listed competitors in our database, 1 of them funded. They include Open Orphan, AWAKN and Clerkenwell Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| openorphan.com | 2017 | London, United Kingdom | 218 | Provider of testing vaccines & antivirals and CRO pharmaceutical services | ||
| awaknlifesciences.com | 2020 | Portishead, United Kingdom | 49 | CRO focused on early stage clinical trial research | ||
| clerkenwellhealth.com | 2020 | London, United Kingdom | $2.33M | CRO focused on conducting early stage clinical development of psychedelic medicines |
Detailed competitors of Molprofiles.co.uk
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Molprofiles.co.uk
Websites that share an audience with Molprofiles.co.uk (molprofiles.co.uk).
Websites whose visitors overlap most with Molprofiles.co.uk. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cerebricon.com | 100% | View details | |||
| altheadx.com | 90% | View details | |||
| biomodels.com | 90% | 2.5K | #9,156,523 | View details | |
| scantox.com | 88% | 21.1K | #1,404,357 | View details | |
| idifarma.com | 86% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Molprofiles.co.uk
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molprofiles.co.uk
Molprofiles.co.uk was founded in 1997.
Molprofiles.co.uk is headquartered in United Kingdom.
Molprofiles.co.uk, established in 1997, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, and early stage. CRO offering Phase I - IIa clinical development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Molprofiles.co.uk's top competitors include AWAKN, Open Orphan and Clerkenwell Health.
Molprofiles.co.uk offers OptiForm Solution Suite, Catalent Spray Drying Technology, and Softgel Technology.
Molprofiles.co.uk has 1 investor. Key investors include Juniper Pharma.
Molprofiles.co.uk operates through Catalent, Inc.
Yes. Molprofiles.co.uk was acquired by Juniper Pharma in September 2013.